Does TEMSIROLIMUS Cause Product use in unapproved indication? 53 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 53 reports of Product use in unapproved indication have been filed in association with TEMSIROLIMUS (Temsirolimus). This represents 3.2% of all adverse event reports for TEMSIROLIMUS.
53
Reports of Product use in unapproved indication with TEMSIROLIMUS
3.2%
of all TEMSIROLIMUS reports
21
Deaths
12
Hospitalizations
How Dangerous Is Product use in unapproved indication From TEMSIROLIMUS?
Of the 53 reports, 21 (39.6%) resulted in death, 12 (22.6%) required hospitalization, and 2 (3.8%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEMSIROLIMUS. However, 53 reports have been filed with the FAERS database.
What Other Side Effects Does TEMSIROLIMUS Cause?
Disease progression (158)
Death (136)
Stomatitis (100)
Anaemia (89)
Neoplasm progression (84)
Vomiting (81)
Diarrhoea (79)
Febrile neutropenia (78)
Pneumonia (76)
Off label use (75)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which TEMSIROLIMUS Alternatives Have Lower Product use in unapproved indication Risk?
TEMSIROLIMUS vs TENAMFETAMINE
TEMSIROLIMUS vs TENAPANOR
TEMSIROLIMUS vs TENECTEPLASE
TEMSIROLIMUS vs TENELIGLIPTIN
TEMSIROLIMUS vs TENIPOSIDE